返回 Agenda
Artificial Intelligence in the Medicines Lifecycle: Delivering Globally for Public and Animal Health
Session Chair(s)
Luis Pinheiro, PharmD, MSc
Senior Epidemiology Expert, RWE, Data Analytics and Methods Taskforce
European Medicines Agency, Netherlands
Aftificial Intelligence (AI) is being adopted across the medicine lifecycle to increase insights into data and improve efficiency of processes, for the benefit of public and animal health. This session will address key elements to enable the safe and responsible use of AI.
Learning Objective : Identify AI opportunities across the medicine lifecycle; Examine the legal ecosystem of AI across jurisdictions and identify opportunities for convergence; Discuss how regulators worldwide are developing guidance to support AI innovation in the medicine lifecycle; State other strategic AI initiatives, including approaches to leveraging AI with healthcare data.
Speaker(s)
Panelist
Julian Beach
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Interim Executive Director, Healthcare Quality and Access
Panelist
Tala Fakhouri, PhD, MPH
FDA, United States
Associate Director for Data Science and Artificial Intelligence, CDER
Panelist
Timothe Menard, PharmD, MSc
F. Hoffmann-La Roche Ltd, Switzerland
Global Head, Quality Excellence Digital | Bioethics Ambassador
Panelist
Gabriel Westman, MD, PhD, MSc
Swedish Medical Products Agency, Sweden
Head of Artificial Intelligence